title: Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease.
abstract: Eighty-eight clomiphene citrate-resistant infertile patients with oligomenorrhoea or amenorrhoea attributable to polycystic ovarian disease were divided at random into three groups. Twenty-nine patients were treated with ovarian electrocautery, 30 with human menopausal gonadotrophins (hMG) and 29 with pure follicle stimulating hormone (FSH). Successful ovulation was induced in 71.4, 70.6 and 66.7% of the cycles in the groups respectively. Ten patients conceived after electrocautery and pure FSH therapy while 15 conceived after hMG medication (chi-squared = 1.6464, P = 0.439). The six-cycle cumulative pregnancy rate in the three consecutive groups was 52.1, 55.4, and 38.3%. Four further pregnancies were achieved after treating 10 patients in the electrocautery group with clomiphene citrate (100 mg/day for 5 days) for 25 cycles. The rate of pregnancy wastage in the corresponding groups was 21.4, 53.3 and 40% (chi-squared = 3.127, P = 0.2039). Ovarian electrocautery is equally effective as hMG and pure FSH in the treatment of PCO patients resistant to clomiphene citrate therapy.
authors.affiliation: Department of Obstetrics and Gynaecology, Faculty of Medicine, Kuwait University Health Science Centre.
authors.forename: A
authors.initials: A
authors.lastname: Abdel Gadir
authors.forename: R S
authors.initials: RS
authors.lastname: Mowafi
authors.forename: H M
authors.initials: HM
authors.lastname: Alnaser
authors.forename: A H
authors.initials: AH
authors.lastname: Alrashid
authors.forename: O M
authors.initials: OM
authors.lastname: Alonezi
authors.forename: R W
authors.initials: RW
authors.lastname: Shaw
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D004564:Electrocoagulation / Q000379:methods*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008596:Menotropins / Q000627:therapeutic use*; D010053:Ovary / Q000601:surgery*; D010062:Ovulation Induction / Q000379:methods; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy / Q000601:surgery*; D011247:Pregnancy; D011256:Pregnancy Outcome
chemical_list: D008596:Menotropins; D005640:Follicle Stimulating Hormone